Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-22

Clinical Trial Update: Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)

View source ↗

Summary

Clinical trial update indicating the Special Drug Use Investigation of lamivudine (ZEFIX) tablets for chronic hepatitis B with HBV-related liver cirrhosis has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZEFIX (lamivudine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Chronic | Status: COMPLETED